Lisa Tomlinson, Author at Rapid Dose Therapeutics

October 21, 2026
Rapid Dose Therapeutics Ships QuickStrip™ Production Line to Callan JMB’s Texas cGMP Facility

October 5, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt and Proposed Issuance of Shares as Payment of Accrued Director Fees

View News Release

August 20, 2026
Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip™ Nicotine Patent, Advancing RDT’s Global Commercialization Strategy

View News Release

July 28, 2026
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN® QuickStrip™ Curcumin Across Canada

View News Release

July 10, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

View News Release

July 7, 2026
Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization

View News Release

April 13, 2026
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets

View News Release

April 6, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

View News Release

March 26, 2026
Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory

View News Release

March 5, 2026
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Secures Patent for QuickStrip™ Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market

View News Release

Latest News